Capsule form The form of delivery of a probiotic can significantly impact absorption, and Berrgren recommends acid-resistant or time-delayed release capsules over powders or liquids
KFFs analysis of newly released Medicare Part D spending data from CMS shows that total gross Medicare spending on the three newest versions of these diabetes medications that have also been recently approved for weight loss Ozempic, Rybelsus, and Mounjaro has skyrocketed in recent years, rising from $57 million in 2018 to $5.7 billion in 2022 (Figure 1)
For weight management, NICE (TA875) recommends semaglutide 2.4 mg (Wegovy) for adults with a BMI of 35 kg/m or greater (or 32.5 kg/m or greater for people from South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean backgrounds) who have at least one weight-related comorbidity
However, the researchers did a sensitivity analysis of a 50 mg version and found that it was not as effective as tirzepatide in non-diabetic patients looking to lose weight
